Rockefeller Capital Management
LEGN icon

Rockefeller Capital Management’s Legend Biotech LEGN Stock Holding History

Rockefeller Capital Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.66M Sell
133,511
-1,353
-1% -$28.9K ﹤0.01% 1287
2026
Q2 		$3.89M Buy
134,864
+51,686
+62% +$1.39M 0.01% 1089
2026
Q1 		$1.5M Buy
83,178
+83,122
+148,432% +$1.58M ﹤0.01% 1423
2025
Q4 		$1.23K Buy
56
+37
+195% +$1.06K ﹤0.01% 4418
2025
Q3 		$620 Buy
+19
New +$702 ﹤0.01% 4244
2022
Q1 		– Sell
-1,000
Closed -$46K – 3982
2021
Q4 		$46K Sell
1,000
-500
-33% -$25.4K ﹤0.01% 2258
2021
Q3 		$75K Buy
+1,500
New +$62.4K ﹤0.01% 1984

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Triata Capital
Triata Capital Hong Kong $531M AUM 34.32% 1-Year Est. Return
Matthews International Capital Management
Matthews International Capital Management San Francisco, California $241M AUM 42.66% 1-Year Est. Return
Davern Capital Partners
Davern Capital Partners Ny, New York $514M AUM 16.9% 1-Year Est. Return
Johnson & Johnson
Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return

Rockefeller Capital Management's LEGN Position: Q3 2026 in Review

Rockefeller Capital Management reduced its Legend Biotech (LEGN) stake by 1% in Q3 2026, selling an estimated $28.9K and leaving 133,511 shares worth $2.66M. The position accounts for ﹤0.01% of the portfolio, ranked #1287.

Rockefeller Capital Management first reported a position in LEGN in Q3 2021 and has held it in 7 quarters since. The position peaked at $3.89M in Q2 2026. 144 funds tracked by Wall St. Rank hold LEGN as of Q3 2026.

  • Rockefeller Capital Management held 133,511 shares of Legend Biotech worth $2.66M as of Q3 2026.
  • Rockefeller Capital Management sold 1,353 Legend Biotech shares in Q3 2026, an estimated $28.9K.
  • Legend Biotech made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #1287 holding.
  • Rockefeller Capital Management first reported a position in Legend Biotech in Q3 2021 and has held it in 7 quarters since.
  • Rockefeller Capital Management's Legend Biotech position peaked at $3.89M in Q2 2026.
  • 144 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2026.

Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.